Share Decline Forecast

Shares have fallen 16.9 % over the past six months, underperforming the industry’s 8.6 % growth, yet the company’s fiscal 2027 consensus EPS estimate remains at $4.58, unchanged over the past 30 days. Consensus revenue for the fourth quarter of fiscal 2026 is pegged at $332.9 million, implying a 6.7 % year‑over‑year increase. HealthEquity identifies data‑security threats as a key risk that could result in fund loss, litigation, regulatory scrutiny, and reputational damage.